Skip to the main content.
BioStrand Logo a subsidiary of IPA
BioStrand Logo a subsidiary of IPA
  • Data Solutions
  • In Silico Discovery
  • Technology
  • Insight Hub
    • Overview
    • Blog
    • eBook
    • Webinars
    • Discover NLP
  • Company
    • Overview
    • Careers
    • News
    • Events
    • Contact us
  • Blog
  • Data Solutions
  • In Silico Discovery
  • Technology
  • Insight Hub
    • Overview
    • Blog
    • eBook
    • Webinars
    • Discover NLP
  • Company
    • Overview
    • Careers
    • News
    • Events
    • Contact us
  • Blog
Powering
Biotherapeutic
Intelligence™
Insight Hub
  • Overview
  • Blog
  • eBooks
  • Webinars
  • Discover NLP
See our latest blogto Blog Listing
Contact usto Contact Page
Powering
Biotherapeutic
Intelligence™
Company
  • Overview
  • Careers
  • Contact
News & Events
  • In the News
  • Conferences & Events
See our latest blogto Blog Listing
Contact usto Contact Page

Powering biotherapeutic intelligence

Stories from the leading edge

Blogs
  • All
  • Omics analysis
  • AI
  • ML
  • Precision medicine
  • Bioinformatics
  • Drug discovery
  • NLP
  • BioStrand Company
  • R&D
  • Company culture
  • Employee spotlight
  • In silico
  • Life sciences data management
  • Antibody discovery
  • Microbiome
  • Protein structure prediction
  • Big data
  • Biomarker
  • Cloud computing
  • Biobank
  • Biomarkers
  • Metadata
Insights into genetics and genomics research, and their leading role in the rapid development of the field.
Featured
Computational biology and drug discovery: what to expect in 2023

Computational biology and drug discovery: what to expect in 2023

The year 2022 in computational biology was largely marked by two main advancements: icon blue arrow
11.01.2023
Most recent
alt=

Defining next-generation biobanks icon blue arrow

27.10.2021
See More
Popular
Explained: how to plot the prediction quality metrics with AlphaFold2 icon blue arrow
Explained: A brief look into AlphaFold 2 icon blue arrow
AI, ML, DL, and NLP: An Overview icon blue arrow
Artificial Intelligence in early phase drug development icon blue arrow
Knowledge Graphs & The Power Of Context icon blue arrow
Creating an AI-ready data foundation for successful AI-enabled drug discovery icon blue arrow
icon blue arrow Back to Insight Hub
Let’s accelerate change. Partner with us.

Subscribe to our blog:

BioStrand Logo
  • Technology
    • Overview
  • In Silico Discovery
    • Overview
  • Data Management
    • Overview
  • Insight Hub
    • Overview
    • Blog
    • eBooks
    • Webinars
    • Discover NLP
  • Company
    • Overview
    • News
    • Events
    • Careers
  • Connect
    • Contact us
    • IPA corporate site
  • Follow Us
  • Twitter
  • LinkedIn
  • YouTube
  • Medium
Sign-up for latest news, blogs and more

BioStrand is an independently operating subsidiary of IPA

  • Privacy
  • Legal Notice
  • Cookie Policy
© 2023 BioStrand BV. All rights reserved. BioStrand BV is an independently operating subsidiary of ImmunoPrecise Antibodies Ltd. BioStrand is a trademark of BioStrand BV.